What is the Timeline of COVID-19 Symptoms?

REVIEWED BY

William Maish, MD MBA MPH

Clinical Product Lead

Published

Last updated

Quick answer:

Day one is the first day of symptoms, not the day of exposure. That gap runs about 5 days or less for each variant studied, down to 3.4 days for Omicron. Symptoms then run a median of 9 days. The hardest stretch is early, since culture-positive samples peak about 2 days after onset. Infectious virus is shed for a median of 5 days, with 24% of people still shedding at day seven.

Read more →

Know your baseline, not just your symptoms

150+ lab tests across immune, metabolic, and hormonal health, across two draws

  • CLIA-certified labs
  • HIPAA compliant
  • Personalized health protocol
Book your test

How long COVID-19 usually lasts

COVID-19 symptoms run for a median of about 9 days in outpatients tracked by daily symptom questionnaires. Half of people finish sooner than that, half take longer. That median describes a typical course, not a set window every infection fits.

Still, a COVID symptoms timeline is an average, and no two infections follow it the same way. Symptoms may start mild like a sore throat, headache, and loss of taste/smell, and some people go on to develop more severe symptoms such as trouble breathing and chest pain. The symptom picture itself keeps shifting with new variants and with vaccination status.

The incubation period before day one

Day one is the first day of symptoms, not the day of exposure. The gap between the two is the incubation period, which runs about 5 days or less per variant, from 5 days for Alpha down to roughly 3.4 days for Omicron. Symptoms can surface anywhere from 2-14 days after exposure.

Pre-symptomatic and asymptomatic describe two different states. Pre-symptomatic means infected and not yet showing symptoms. Asymptomatic means infected and never developing them. Most people carried detectable virus before symptoms began, but only one in five shed the infectious virus that early.

The first symptoms of COVID-19

COVID-19 rarely announces itself all at once. The first symptoms arrive over a day or two, clustered in the nose, throat, and chest. The full list of possible symptoms is much wider than that.

  • Sore throat: sharp or scratchy, often the first thing noticed.
  • Fatigue: heavier than the day's activity would explain.
  • Congestion or runny nose: the same picture as a bad cold.
  • Headache: dull and persistent rather than sudden.
  • Low-grade fever or chills: sometimes mild enough to miss.

The old mental model is out of date. Sore throat was reported by 70.5% of vaccinated people during Omicron, against 16.7% for loss of smell. Symptoms alone cannot separate COVID-19 from flu, because the two illnesses share several of the same symptoms.

Join 150,000+ others building better health

Get the science behind better health, every week.

By clicking “Subscribe” you agree to our Terms of Service and Privacy Policy.

The COVID-19 symptoms timeline, day by day

An uncomplicated course usually follows a recognizable arc, and plenty of infections take their own route without being abnormal. Day numbers count from the first day of symptoms, not from exposure.

Day rangeWhat typically happensWhat to do
Days 1-3Sore throat, congestion, fatigue, low-grade feverTest and start tracking symptoms
Days 4-7Cough, body aches, and fever most pronouncedWatch this window most closely
Days 8-10Fever settles, energy begins returning in milder coursesResume activity gradually
Days 11-14 and beyondResidual cough and waves of fatigueRaise anything still worsening with a clinician

Digestive symptoms sit outside that pattern. Early-pandemic cohorts put diarrhea at 12.4% of patients and nausea or vomiting at 9%.

The worst days of a COVID-19 infection

For most people the hardest stretch arrives early rather than late. Symptom onset comes a median of 3 days before peak viral load, and culture-positive samples peak about 2 days after symptoms start. By the time a cough feels worst, the virus itself is usually on the way down.

That early window is also the antiviral window. The FDA approved nirmatrelvir with ritonavir for high-risk adults, started within 5 days of symptom onset. The trial behind that approval enrolled unvaccinated high-risk adults. Starting within 3 days left 0.77% hospitalized or dead by day 28, with no deaths, against 7.01% on placebo. Not every infection follows that arc, and severity is what changes it.

How the timeline differs by severity

A mild course and a severe one often open the same way. What separates them is how far the illness travels, since mild symptoms can progress to severe ones. Both are typical courses, not a way to grade your own.

MilestoneMild courseModerate to severe course
Symptom peakWithin the first few daysLater, and longer
Respiratory involvementNose and throatChest, with breathlessness
Antiviral windowSame start limit in bothEligibility-dependent
Return to usual healthBack to baseline within a couple of weeksA longer tail

That five-day limit applies only to adults at high risk of progression. Age stretches the tail as well. About 2 weeks after testing, 26% of adults aged 18 to 34 had not returned to their usual health. Among those 50 and over, it was 47%. Shortness of breath is never a stage to wait out.

How long you stay contagious, and when to test

Infectious virus is shed for a median of about 5 days from symptom onset. Plenty of infections run longer, with 65% still shedding infectious virus at 5 days and 24% at 7 days. How contagious you are rarely matches how well you feel.

Get 150+ lab tests from home

Two blood draws a year. A full picture of your health, explained in plain language.

Book your test

The signs COVID-19 is getting better

Fever breaking and staying down, energy returning, and a loosening cough are the ordinary signs an uncomplicated infection is resolving. Viral clearance follows a similar arc, with 55% testing negative by day 14.

Feeling better and being back to normal are two different milestones. Roughly 2 weeks after testing, 35% of symptomatic adults had not returned to their usual state of health. Cough, fatigue, and shortness of breath were the most likely stragglers. Those 2020 figures predate vaccines, so read them as evidence that a slow tail is common.

When COVID-19 symptoms need emergency care

Severe illness can develop after a mild start, so the whole course is worth watching, not just the first days. If any of these signs appear, call 911 or call ahead to the nearest emergency facility. These signs mean emergency care now, not a wait-and-see period.

  • Trouble breathing.
  • Persistent pain or pressure in the chest.
  • New confusion.
  • Inability to wake or stay awake.
  • Pale, gray, or blue-colored skin, lips, or nail beds, depending on skin tone.

When lingering symptoms become long COVID

Post-COVID-19 condition, commonly called long COVID, is recognized in someone with a history of probable or confirmed infection. It applies when symptoms are still present around 3 months from onset, have lasted at least 2 months, and cannot be explained by another condition.

In practice that looks like fatigue, shortness of breath, and cognitive difficulty, and it disrupts everyday functioning. Symptoms may be new after an apparent recovery, or carried through from the first illness, and they fluctuate. One good week is not proof of recovery. Symptoms this persistent deserve a clinical workup, not self-assessment.

Track what recovery looks like with Superpower

A COVID symptoms timeline ends when the symptoms do. How quickly energy, sleep, and inflammation return to baseline is a longer question. A Superpower membership includes two blood draws, an initial baseline plus a partial re-draw of your most critical markers, for 150+ lab tests across immune, metabolic, and hormonal health. Your results sit in one place, tracked over time, with a personalized action plan.

Recovery is easier to read against a baseline than against how you remember feeling. Start your Superpower membership and turn a single set of results into ongoing, on-demand support.

Frequently Asked Questions

References

  1. Vashi B, Pettrone K, Wilson CS, et al. COVID-19 symptom severity and duration among outpatients, July 2021-May 2023: the PROTECT observational study. *PLoS One*. 2025;20(2):e0314518. doi:10.1371/journal.pone.0314518
  2. Centers for Disease Control and Prevention. Symptoms of COVID-19. Updated March 10, 2025. Accessed September 20, 2026.
  3. Wu Y, Kang L, Guo Z, Liu J, Liu M, Liang W. Incubation period of COVID-19 caused by unique SARS-CoV-2 strains: a systematic review and meta-analysis. *JAMA Netw Open*. 2022;5(8):e2228008. doi:10.1001/jamanetworkopen.2022.28008
  4. Hakki S, Zhou J, Jonnerby J, et al. Onset and window of SARS-CoV-2 infectiousness and temporal correlation with symptom onset: a prospective, longitudinal, community cohort study. *Lancet Respir Med*. 2022;10(11):1061-1073. doi:10.1016/S2213-2600(22)00226-0
  5. Menni C, Valdes AM, Polidori L, et al. Symptom prevalence, duration, and risk of hospital admission in individuals infected with SARS-CoV-2 during periods of omicron and delta variant dominance: a prospective observational study from the ZOE COVID Study. *Lancet*. 2022;399(10335):1618-1624. doi:10.1016/S0140-6736(22)00327-0
  6. Tariq R, Saha S, Furqan F, Hassett L, Pardi D, Khanna S. Prevalence and mortality of COVID-19 patients with gastrointestinal symptoms: a systematic review and meta-analysis. *Mayo Clin Proc*. 2020;95(8):1632-1648. doi:10.1016/j.mayocp.2020.06.003
  7. Smith-Jeffcoat SE, Mellis AM, Grijalva CG, et al. SARS-CoV-2 viral shedding and rapid antigen test performance — Respiratory Virus Transmission Network, November 2022-May 2023. *MMWR Morb Mortal Wkly Rep*. 2024;73(16):365-371. doi:10.15585/mmwr.mm7316a2
  8. US Food and Drug Administration. FDA approves first oral antiviral for treatment of COVID-19 in adults. May 25, 2023. Accessed September 20, 2026.
  9. Hammond J, Leister-Tebbe H, Gardner A, et al. Oral nirmatrelvir for high-risk, nonhospitalized adults with Covid-19. *N Engl J Med*. 2022;386(15):1397-1408. doi:10.1056/NEJMoa2118542
  10. Tenforde MW, Kim SS, Lindsell CJ, et al. Symptom duration and risk factors for delayed return to usual health among outpatients with COVID-19 in a multistate health care systems network — United States, March-June 2020. *MMWR Morb Mortal Wkly Rep*. 2020;69(30):993-998. doi:10.15585/mmwr.mm6930e1
  11. Soni A, Herbert C, Lin H, et al. Performance of rapid antigen tests to detect symptomatic and asymptomatic SARS-CoV-2 infection: a prospective cohort study. *Ann Intern Med*. 2023;176(7):975-982. doi:10.7326/M23-0385
  12. Soriano JB, Murthy S, Marshall JC, Relan P, Diaz JV; WHO Clinical Case Definition Working Group on Post-COVID-19 Condition. A clinical case definition of post-COVID-19 condition by a Delphi consensus. *Lancet Infect Dis*. 2022;22(4):e102-e107. doi:10.1016/S1473-3099(21)00703-9

Led by doctors with 40 years of health and longevity expertise

Dr. Anant Vinjamoori

Dr. Anant Vinjamoori, MD

Chief Longevity Officer, Superpower

Dr. Leigh Erin Connealy

Dr. Leigh Erin Connealy, MD

Clinician & Founder of The Centre for New Medicine

Dr. Robert Lufkin

Dr. Robert Lufkin, MD

Physician & UCLA Medical School Professor, NYT bestselling author

Dr. Abe Malkin

Dr. Abe Malkin, MD

Founder & Medical Director of Concierge MD

Biological age 32 — a Superpower member portraitA health system built around you — test, understand, optimize150+ biomarkers across 2 blood drawsWhat to expect with Superpower — week 1 to month 3Trusted by 64,000+ customers — member reviewsBetter than the status quo — Superpower vs the old way60% of members found something a doctor missed — member survey
Daniel OSuperpower memberDavid LSuperpower memberRachel DSuperpower memberCamelia VSuperpower member

4.6 · 64,000+ members

Superpower health membership

Find early signs of 1,000+ conditions - then act, retest, and see what changed.

$349

/year*

150+ biomarkers annually across baseline + retest

Personalized plan that turns results into action

Superpower AI and on-demand care team

Results in 10 days or less

At-home or 2,000+ labs nationwide**

Yearly membership$0.96 / dayHSA/FSA eligible

*Pricing may vary for members in New York and New Jersey

**At-home labs for an additional cost

What we test

TestosteroneFree T4Vitamin DApoBHbA1cThyroid (TSH)hs-CRPFerritinCortisolFasting insulin

60%

found something a doctor missed

93%

rated it more useful than their checkup

77%

found something new in their results

Superpower member survey, 90 days post action plan (n=143).

How does the Superpower membership work?

We test 150+ biomarkers annually across two blood draws. Your baseline test paints a comprehensive picture of your health, and your dashboard shows what’s working, what needs attention, and what to do next. Superpower AI and your care team help you take action across lifestyle, supplements, and treatments. Then we retest to track your progress and continue refining your plan.

Can I cancel anytime?

Yes. You can cancel anytime, no fees. Your membership stays active through the end of your paid year.

How often should I test?

Your membership includes two blood tests per year: one to establish your baseline, and one to see whether your plan improved biomarkers that were out of range or not yet optimized. You can add other diagnostics anytime through the app or with help from your care team.

When will I get my results?

Book your draw at any of 2,000+ partner labs or at-home. Results are typically ready in about a week and land in the Superpower app.

What the 100+ panel measures

All 101 markers in your annual baseline draw, organized by system. Nothing here is an upsell.

Heart & Vascular Health

26

  • Apolipoprotein B
  • Atherogenic Coefficient
  • Atherogenic Index of Plasma
  • Castelli Risk Index I
  • Castelli Risk Index II
  • HDL Cholesterol
  • LDL Cholesterol
  • LDL/HDL Ratio
  • Cholesterol, Total
  • Non-HDL Cholesterol
  • Cholesterol/HDL Ratio
  • Carbon Dioxide, Total
  • High-sensitivity CRP
  • hsCRP-to-Albumin Ratio (CAR)
  • GGT-to-HDL Cholesterol Ratio
  • LDL-C to Apolipoprotein B Ratio (LDL-C/ApoB)
  • LDL Cholesterol / Total Cholesterol (Mass Ratio)
  • Monocyte-to-HDL Ratio (MHR)
  • Neutrophil-to-HDL Cholesterol Ratio (NHR)
  • Non-HDL Cholesterol-to-Apolipoprotein B Ratio (Non-HDL-C/ApoB)
  • NON-HDL Total Cholesterol Ratio
  • Triglyceride HDL Molar Ratio
  • Triglycerides
  • Triglyceride-to-Apolipoprotein B Ratio (TG/ApoB)
  • TyG Index
  • Uric Acid

Metabolic Health

4

  • Estim. Avg Glu (eAG)
  • Eag (mmol/l)
  • Glucose
  • Hemoglobin A1c

Energy

1

  • Cortisol

Liver Health

15

  • Albumin/Globulin Ratio
  • Albumin
  • Alkaline Phosphatase (ALP)
  • Alanine Aminotransferase (ALT)
  • Aspartate Aminotransferase (AST)
  • Bilirubin Direct
  • Bilirubin Indirect
  • Bilirubin, Total
  • Bilirubin-to-Albumin Ratio
  • Ferritin
  • Ferritin-to-Albumin Ratio
  • y-Glutamyl Transferase (GGT)
  • Globulin, Total
  • Indirect-to-Direct Bilirubin Ratio
  • Protein, Total

Kidney

11

  • Calcium
  • Chloride
  • Corrected Calcium (Albumin-adjusted)
  • Creatinine
  • Estimated Glomerular Filtration Rate (eGFR)
  • Potassium
  • Sodium
  • BUN/Creatinine Ratio
  • Blood Urea Nitrogen (BUN)
  • Urea-to-Creatinine Ratio
  • Uric Acid-to-HDL Cholesterol Ratio (UHR)

Sex Hormones

7

  • DHEA-Sulfate (DHEA-S)
  • Free Androgen Index
  • Sex Hormone Binding Globulin (SHBG)
  • Free Testosterone
  • Testosterone, Bioavailable
  • Testosterone, Total
  • Testosterone-to-Estradiol Ratio (T/E₂)

Thyroid Health

4

  • Free Thyroxine Index
  • T3 Uptake
  • T4 (thyroxine) Total
  • Thyroid-Stimulating Hormone (TSH)

Nutrients

13

  • Vitamin D
  • Red Cell Dist Width (RDW)
  • Hematocrit
  • Hemoglobin
  • Total Iron Binding Capacity (TIBC)
  • Iron
  • Iron Saturation
  • Mean Cell Hemoglobin (MCH)
  • Mean Corpuscular Hemoglobin Concentration (MCHC)
  • Mean Cell Volume (MCV)
  • Platelet-to-WBC Ratio (PWR)
  • Red Blood Cells
  • RDW MCV Ratio

Immune System

12

  • Basophils
  • Baso (Absolute)
  • Eosinophils
  • Eos (Absolute)
  • Lymphocytes
  • Lymphs (Absolute)
  • Monocytes
  • Monocytes (Absolute)
  • Neutrophils
  • Neutrophils (Absolute)
  • Mean Platelet Volume
  • Platelet Count

Inflammation

8

  • Lymphocyte-to-Monocyte Ratio (LMR)
  • Monocyte-to-Lymphocyte Ratio (MLR)
  • Neutrophil-to-Lymphocyte-Platelet Ratio (NLPR)
  • Neutrophil-to-Lymphocyte Ratio (NLR)
  • Platelet-to-Lymphocyte Ratio (PLR)
  • Systemic Immune-Inflammation Index
  • Systemic Inflammation Response Index (SIRI)
  • White Blood Cells
Get my health baseline

The full list of 100+ markers and 8 specialty add-ons available at superpower.com/biomarkers.